Olli Dufva

10PUBLICATIONS
91CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 14, 2026
TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

|Apr 27, 2026
Multimodal immunopharmacologic screens identify drugs rewiring the cancer-immune interface.

|Jan 10, 2025
High-throughput drug screening identifies SMAC mimetics as enhancers of NK-cell cytotoxicity in chronic myeloid leukemia.

Petra Nygrén, Jonas Bouhlal, Emmi Jokinen

|Apr 17, 2024
Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell Lymphoma.

Leo Meriranta, Selma Sorri, Kanutte Huse

|Feb 07, 2024
Tracing back primed resistance in cancer via sister cells.

Jun Dai, Shuyu Zheng, Matías M Falco

|Nov 03, 2023
Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation.

Jani Huuhtanen, Shady Adnan-Awad, Jason Theodoropoulos

Pageof 2

Frequent Collaborators

8 joint publications

Satu Mustjoki

4 joint publications

Shady Adnan-Awad

4 joint publications

Jonas Bouhlal

3 joint publications

Tiina Kasanen